Citius Pharmaceuticals, Inc. Share-based Compensation Arrangement by Share-based Payment Award, Non-Option Equity Instruments, Granted
Citius Pharmaceuticals, Inc. (CTXR) reported Share-based Compensation Arrangement by Share-based Payment Award, Non-Option Equity Instruments, Granted of 11.73 million shares for the 12-month period ending 2023-09-30, per its 10-K filed 2023-12-29.
Discontinued › Notes › Compensation Related Costs › Share-Based Payment Arrangement, Disclosure
us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsGranted · last filed 2023-12-29
- Citius Pharmaceuticals, Inc. share-based compensation arrangement by share-based payment award, non-option equity instruments, granted for the quarter ending 2023-09-30 was 0.00 shares.
- Citius Pharmaceuticals, Inc. share-based compensation arrangement by share-based payment award, non-option equity instruments, granted for the quarter ending 2023-06-30 was -75.00K shares.
- Citius Pharmaceuticals, Inc. share-based compensation arrangement by share-based payment award, non-option equity instruments, granted for the quarter ending 2023-03-31 was 11.78M shares.
- Citius Pharmaceuticals, Inc. share-based compensation arrangement by share-based payment award, non-option equity instruments, granted for the quarter ending 2022-12-31 was 35.00K shares, a 99.18% decline year-over-year.
- Citius Pharmaceuticals, Inc. share-based compensation arrangement by share-based payment award, non-option equity instruments, granted for fiscal 2023 was 11.73M shares, a 202.06% increase from fiscal 2022.
- Citius Pharmaceuticals, Inc. share-based compensation arrangement by share-based payment award, non-option equity instruments, granted for fiscal 2022 was 3.88M shares, a 48.41% decline from fiscal 2021.
- Citius Pharmaceuticals, Inc. share-based compensation arrangement by share-based payment award, non-option equity instruments, granted for fiscal 2021 was 7.53M shares, a 205.48% increase from fiscal 2020.
- Citius Pharmaceuticals, Inc. share-based compensation arrangement by share-based payment award, non-option equity instruments, granted for fiscal 2020 was 2.46M shares, a 125.98% increase from fiscal 2019.
| Period end | Share-based Compensation Arrangement by Share-based Payment Award, Non-Option Equity Instruments, Granted 3 month | Share-based Compensation Arrangement by Share-based Payment Award, Non-Option Equity Instruments, Granted 6 month | Share-based Compensation Arrangement by Share-based Payment Award, Non-Option Equity Instruments, Granted 9 month | Share-based Compensation Arrangement by Share-based Payment Award, Non-Option Equity Instruments, Granted 12 month |
|---|---|---|---|---|
| 2023-09-30 | 0.00 shares derived: 10-K 12 month − 10-Q 9 month · filed 2023-12-29 | -75.00K shares derived: sum of 2 quarters · filed 2023-12-29 | 11.70M shares derived: sum of 3 quarters · filed 2023-12-29 | 11.73M shares 10-K · filed 2023-12-29 |
| 2023-06-30 | -75.00K shares derived: 10-Q 9 month − 10-Q 6 month · filed 2023-08-14 | 11.70M shares derived: sum of 2 quarters · filed 2023-08-14 | 11.73M shares 10-Q · filed 2023-08-14 | 11.73M shares derived: sum of 4 quarters · filed 2023-08-14 |
| 2023-03-31 | 11.78M shares derived: 10-Q 6 month − 10-Q 3 month · filed 2023-05-12 | 11.81M shares 10-Q · filed 2023-05-12 | 11.81M shares derived: sum of 3 quarters · filed 2023-05-12 | 11.73M shares derived: sum of 4 quarters · filed 2023-05-12 |
| 2022-12-31 | 35.00K shares 10-Q · filed 2023-02-10 | 35.00K shares derived: sum of 2 quarters · filed 2023-02-10 | -45.00K shares derived: sum of 3 quarters · filed 2023-02-10 | -345.00K shares derived: sum of 4 quarters · filed 2023-02-10 |
| 2022-09-30 | 0.00 shares derived: 10-K 12 month − 10-Q 9 month · filed 2022-12-22 | -80.00K shares derived: sum of 2 quarters · filed 2022-12-22 | -380.00K shares derived: sum of 3 quarters · filed 2022-12-22 | 3.88M shares 10-K · filed 2022-12-22 |
| 2022-06-30 | -80.00K shares derived: 10-Q 9 month − 10-Q 6 month · filed 2022-08-11 | -380.00K shares derived: sum of 2 quarters · filed 2022-08-11 | 3.88M shares 10-Q · filed 2022-08-11 | 2.79M shares derived: sum of 4 quarters · filed 2022-08-11 |
| 2022-03-31 | -300.00K shares derived: 10-Q 6 month − 10-Q 3 month · filed 2022-05-12 | 3.96M shares 10-Q · filed 2022-05-12 | 2.87M shares derived: sum of 3 quarters · filed 2022-05-12 | 10.26M shares derived: sum of 4 quarters · filed 2022-05-12 |
| 2021-12-31 | 4.26M shares 10-Q · filed 2022-02-10 | 3.17M shares derived: sum of 2 quarters · filed 2022-02-10 | 10.55M shares derived: sum of 3 quarters · filed 2022-02-10 | 10.43M shares derived: sum of 4 quarters · filed 2022-02-10 |
| 2021-09-30 | -1.10M shares derived: 10-K 12 month − 10-Q 9 month · filed 2021-12-15 | 6.29M shares derived: sum of 2 quarters · filed 2021-12-15 | 6.17M shares derived: sum of 3 quarters · filed 2021-12-15 | 7.53M shares 10-K · filed 2021-12-15 |
| 2021-06-30 | 7.39M shares derived: 10-Q 9 month − 10-Q 6 month · filed 2021-08-12 | 7.26M shares derived: sum of 2 quarters · filed 2021-08-12 | 8.63M shares 10-Q · filed 2021-08-12 | 8.01M shares derived: sum of 4 quarters · filed 2021-08-12 |
| 2021-03-31 | -125.00K shares derived: 10-Q 6 month − 10-Q 3 month · filed 2021-05-13 | 1.24M shares 10-Q · filed 2021-05-13 | 615.00K shares derived: sum of 3 quarters · filed 2021-05-13 | 595.00K shares derived: sum of 4 quarters · filed 2021-05-13 |
| 2020-12-31 | 1.36M shares 10-Q · filed 2021-02-11 | 740.00K shares derived: sum of 2 quarters · filed 2021-02-11 | 720.00K shares derived: sum of 3 quarters · filed 2021-02-11 | 3.72M shares derived: sum of 4 quarters · filed 2021-02-11 |
| 2020-09-30 | -625.00K shares derived: 10-K 12 month − 10-Q 9 month · filed 2020-12-16 | -645.00K shares derived: sum of 2 quarters · filed 2020-12-16 | 2.35M shares derived: sum of 3 quarters · filed 2020-12-16 | 2.46M shares 10-K · filed 2020-12-16 |
| 2020-06-30 | -20.00K shares derived: 10-Q 9 month − 10-Q 6 month · filed 2020-08-14 | 2.98M shares derived: sum of 2 quarters · filed 2020-08-14 | 3.09M shares 10-Q · filed 2020-08-14 | 3.09M shares derived: sum of 4 quarters · filed 2020-08-14 |
| 2020-03-31 | 3.00M shares derived: 10-Q 6 month − 10-Q 3 month · filed 2020-05-14 | 3.11M shares 10-Q · filed 2020-05-14 | 3.11M shares derived: sum of 3 quarters · filed 2020-05-14 | 2.98M shares derived: sum of 4 quarters · filed 2020-05-14 |
| 2019-12-31 | 110.00K shares 10-Q · filed 2020-02-13 | 110.00K shares derived: sum of 2 quarters · filed 2020-02-13 | -15.00K shares derived: sum of 3 quarters · filed 2020-02-13 | -60.00K shares derived: sum of 4 quarters · filed 2020-02-13 |
| 2019-09-30 | 0.00 shares derived: 10-K 12 month − 10-Q 9 month · filed 2019-12-16 | -125.00K shares derived: sum of 2 quarters · filed 2019-12-16 | -170.00K shares derived: sum of 3 quarters · filed 2019-12-16 | 1.09M shares 10-K · filed 2019-12-16 |
| 2019-06-30 | -125.00K shares derived: 10-Q 9 month − 10-Q 6 month · filed 2019-08-14 | -170.00K shares derived: sum of 2 quarters · filed 2019-08-14 | 1.09M shares 10-Q · filed 2019-08-14 | 2.35M shares derived: sum of 4 quarters · filed 2019-08-14 |
| 2019-03-31 | -45.00K shares derived: 10-Q 6 month − 10-Q 3 month · filed 2019-05-15 | 1.22M shares 10-Q · filed 2019-05-15 | 2.48M shares derived: sum of 3 quarters · filed 2019-05-15 | 2.48M shares derived: sum of 4 quarters · filed 2019-05-15 |
| 2018-12-31 | 1.26M shares 10-Q · filed 2019-02-14 | 2.52M shares derived: sum of 2 quarters · filed 2019-02-14 | 2.52M shares derived: sum of 3 quarters · filed 2019-02-14 | 2.52M shares derived: sum of 4 quarters · filed 2019-02-14 |
| 2018-09-30 | 1.26M shares derived: 10-K 12 month − 10-Q 9 month · filed 2018-12-11 | 1.26M shares derived: sum of 2 quarters · filed 2018-12-11 | 1.26M shares derived: sum of 3 quarters · filed 2018-12-11 | 1.26M shares 10-K · filed 2018-12-11 |
| 2018-06-30 | 0.00 shares derived: 10-Q 9 month − 10-Q 6 month · filed 2018-08-14 | 0.00 shares derived: sum of 2 quarters · filed 2018-08-14 | 799.00 shares 10-Q · filed 2018-08-14 | -274.20K shares derived: sum of 4 quarters · filed 2018-08-14 |
| 2018-03-31 | 0.00 shares derived: 10-Q 6 month − 10-Q 3 month · filed 2018-05-11 | 799.00 shares 10-Q · filed 2018-05-11 | -274.20K shares derived: sum of 3 quarters · filed 2018-08-14 | |
| 2017-12-31 | 799.00 shares 10-Q · filed 2018-02-14 | -274.20K shares derived: sum of 2 quarters · filed 2018-08-14 | ||
| 2017-09-30 | -275.00K shares derived: 10-Q 12 month − 10-Q 9 month · filed 2018-08-14 | 799.00 shares 10-Q · filed 2018-08-14 | ||
| 2017-06-30 | 275.80K shares 10-Q · filed 2017-08-14 | |||
| 2016-09-30 | 284.48K shares 10-Q · filed 2017-08-14 | 284.48K shares 10-K · filed 2017-12-13 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Korsana Biosciences, Inc. (CYCN) | United States | $0.016B | |
| Lantern Pharma Inc. (LTRN) | United States | $0.015B | -2.87 |
| Anebulo Pharmaceuticals, Inc. (ANEB) | United States | $0.015B | |
| ACTUATE THERAPEUTICS, INC. (ACTU) | United States | $0.015B | |
| Pasithea Therapeutics Corp. (KTTA) | United States | $0.017B | -0.81 |
| Tvardi Therapeutics, Inc. (TVRD) | United States | $0.014B | |
| Vyome Holdings, Inc (HIND) | United States | $0.014B | -1.38 |
| Allarity Therapeutics, Inc. (ALLR) | United States | $0.017B | -1.66 |
| BullFrog AI Holdings, Inc. (BFRG) | United States | $0.014B | |
| PALATIN TECHNOLOGIES INC (PTN) | United States | $0.017B | -5.36 |